PSY 2406: Psychopharmacology

May 8, 2020

Robinson, D. L., Hermans, A., Seipel, A. T., & Wightman, R. M. (2008). Monitoring rapid chemical communication in the brain. Chemical Reviews, 108(7), 2554–2584. https://doi.org/10.1021/cr068081q

May 15 & May 22, 2020

Rush A.J., Trivedi, M.H., Wisniewski, S.R., Nierenberg, A.A., Stewart, J.W., Warden, D., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163, 1905-1917.

Miller, B. R., & Hen, R. (2015). The current state of the neurogenic theory of depression and anxiety. Current Opinion in Neurobiology, 30, 51-58.

Diaz Granados, N., Ibrahim, L., Brutsche, N., Ameli, R., Henter, I. D., Luckenbaugh, D. A., ... & Zarate Jr, C. A. (2010). Rapid resolution of suicidal ideation after a single infusion of an NMDA antagonist in patients with treatment-resistant major depressive disorder. The Journal of Clinical Psychiatry, 71(12), 1605.  Request through Document Delivery/Interlibrary Loan

Spielmans, G. I., Berman, M. I., Linardatos, E., Rosenlicht, N. Z., Perry, A., & Tsai, A. C. (2013). Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS medicine, 10(3), e1001403.

Cuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2014). Adding psychotherapy to antidepressant medication in depression and anxiety disorders: A meta-analysis. World Psychiatry, 13(1), 56-67.

May 29, 2020

Brunet A, Saumier D, Liu A, et al. (2018). Reduction of PTSD symptoms with pre-reactivation propranolol therapy: A randomized controlled trial. American Journal of Psychiatry, 175(5):427-433.

Guina, J., Rossetter, S. R., DeRHODES, B. J., Nahhas, R. W., & Welton, R. S. (2015). Benzodiazepines for PTSD: a systematic review and meta-analysis. Journal of Psychiatric Practice, 21(4), 281-303.

McEwen, B. S., Bowles, N. P., Gray, J. D., Hill, M. N., Hunter, R. G., … & Nasca, C. (2015). Mechanisms of stress in the brain. Nature Neuroscience, 18(10), 1353-1363. https://doi.org/10.1083/nn.4086

Limosin, F., & Schuster, J. P. (2015, Nov.). Usage et mésusage des benzodiazépines chez le sujet âgé. European Psychiatry, 30(8), S44-S44. (French language) 

Lewis, S., & Lieberman, J.A. (2008). CATIE and CUtLASS: Can we handle the truth? The British Journal of Psychiatry, 192,161-163.

June 5, 2020

Reus, V. I., Fochtmann, L. J., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M., Jibson, M. D., ... & Wills, C. D. (2016). The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. American Journal of Psychiatry, 173(5), 543-546.

Howes, O. D., & Kapur, S. (2009). The dopamine hypothesis of schizophrenia: Version III—The final common pathway, Schizophrenia Bulletin, 35(3), 549–562. https://doi.org/10.1093/schbul/sbp006

Lieberman, J. A., Stroup, S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S., Davis, S. M., Davis, C. E., Lebowitz, B. D., Severe, J., & Hsiao, J. K.. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353(12), 1209-23.

Lewis, S., & Lieberman, J.A. (2008). CATIE and CUtLASS: Can we handle the truth? The British Journal of Psychiatry, 192,161-163.

June 12, 2020

Ashok, A. H., Marques, T. R., Jauhar, S., Nour, M. M., Goodwin, G. M., Young, A. H., & Howes, O. D. (2017). The dopamine hypothesis of bipolar affective disorder: The state of the art and implications for treatment. Molecular Psychiatry, 22(5), 666.

Loebel, A., Cucchiaro, J., Silva, R., Kroger, H., Hsu, J., Sarma, K., & Sachs, G. (2014). Lurasidone monotherapy in the treatment of bipolar I depression: A randomized, double-blind, placebo-controlled study. American Journal of Psychiatry, 171(2),160-168.